S100A11 (calgizzarin) is released by circulating mononuclear cells and its elevated plasma levels distinguish systemic lupus erythematosus patients from healthy individuals.

S100A11 (calgizzarin) is released by circulating mononuclear cells and its elevated plasma levels distinguish systemic lupus erythematosus patients from healthy individuals.
Clin Exp Rheumatol. 2019 Feb 04;
Authors: Cerezo LA, Šumová B, Hulejová H, Štorkánová H, Szczuková L, Tomčík M, Bečvář R, Pavelka K, Vencovský J, Závada J, Šenolt L
Abstract

PMID: 30719969 [PubMed - as supplied by publisher]

Source: Clinical and Experimental Rheumatology - February 7, 2019 Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research